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Plasmamembrane (PM)-boundGTPaseRap1 recruits
theRap1-interacting-adaptor-molecule (RIAM),which
in turn recruits talin to bind and activate integrins.
However, it is unclear how RIAM recruits talin and
why its close homolog lamellipodin does not. Here,
we report that, although RIAM possesses two talin-
binding sites (TBS1 and TBS2), only TBS1 is capable
of recruiting cytoplasmic talin to the PM, and the R8
domain is the strongest binding site in talin. Crystal
structure of an R7R8:TBS1 complex reveals an unex-
pected kink in the TBS1 helix that is not shared in
the homologous region of lamellipodin. This kinked
helix conformation is required for the colocalization
of RIAM and talin at the PM and proper activation of
integrin.Our findingsprovide the structural andmech-
anistic insight into talin recruitment by RIAM that un-
derlies integrin activation and explain the differential
functions of the otherwise highly homologous RIAM
and lamellipodin in integrin signaling.
INTRODUCTION
Integrin signalingpromotes cell proliferation,migration, andadhe-
sion and regulates cell survival via crosstalkwith receptor tyrosine
kinases (Clemmons and Maile, 2005; Hood et al., 2003; Menter
and Dubois, 2012; Parsons, 2003; Ratnikov et al., 2005). The ec-
todomains of activated integrin bind the extracellular matrix
(ECM) and trigger the outside-in signaling pathway that activates
the FAK-Src signaling cascade (Arias-Salgadoet al., 2003; Huang
et al., 1993). Integrins are activated primarily by the cytoskeletal
protein talin (Tadokoro et al., 2003; Wegener et al., 2007). Talin
also plays an important role in promoting cancer progression
and metastasis (Desiniotis and Kyprianou, 2011). In particular,
the expression of talin is upregulated in many primary tumors
and its overexpression correlates with metastases of oral squa-
mous cell carcinomas and prostate cancers (Lai et al., 2011; Sa-
kamoto et al., 2010). Therefore, talin may serve as a prognostic
marker and/or drug target for cancer therapeutics.1810 Structure 22, 1810–1820, December 2, 2014 ª2014 Elsevier LtdVertebrates possess two isoforms of talin, talin1 and talin2.
Talin1 is ubiquitously expressed in mammalian cells, whereas
talin2 is primarily expressed in the heart (Monkley et al., 2001).
Talin1 is also more important in activating integrin in platelets
(Nieswandt et al., 2007; Petrich et al., 2007). Activation of integ-
rins by talin is initiated by a Rap1-induced signaling pathway
known as the inside-out pathway (Banno and Ginsberg, 2008;
Bivona et al., 2004; Bos et al., 2003; Lee et al., 2009; Wynne
et al., 2012). Activated Rap1 recruits an effector protein, Rap1-
interacting adaptor molecule (RIAM), which in turn recruits talin
to the plasma membrane (PM) (Lafuente et al., 2004; Lee et al.,
2009; Wynne et al., 2012). Thus, the specific binding to both
Rap1 and talin allows RIAM to play a key role in this pathway
by linking cytoplasmic talin to the PM-anchored Rap1 (Lee
et al., 2009; Wynne et al., 2012; Zhang et al., 2014). Talin is
composed of a 4-domain ‘‘head’’ region and a ‘‘rod’’ region con-
sisting of 13 helical bundle domains (R1–R13) (Figure 1A) (Goult
et al., 2013b; Moser et al., 2009; Ye et al., 2014). Following its
recruitment to the PM by RIAM, talin binds to the intracellular
tail of the integrin b subunit via the F3 domain from the head re-
gion and, in doing so, switches integrin from a low- to a high-af-
finity state (Wegener et al., 2007). This activity is suppressed by a
competitive intramolecular autoinhibitory interaction between
the F3 domain in the head region and the R9 domain in the rod
region. Talin also recruits other cytoskeletal proteins, such as
actin and vinculin, to stabilize the integrin-mediated focal adhe-
sions (Figure 1A) (Humphries et al., 2007).
RIAM recruits talin to the PM via RIAM’s N-terminal region
(Goult et al., 2013b; Lee et al., 2009). RIAM translocates to
the PM via interactions of its Ras-associating domain (RA) with
Rap1 GTPase and its pleckstrin-homology domain (PH) with
membrane lipid PI(4,5)P2 (Figure 1B) (Wynne et al., 2012). Multi-
ple interacting sites have been identified in RIAM and in the
talin rod domains (Goult et al., 2013b; Lee et al., 2009). The first
identified talin-binding site in RIAM, known as TBS1 (residues
1–30), may interact with several talin rod domains (Goult et al.,
2013b). Interestingly, TBS1 also interacts with the vinculin
domain 1 (Vd1), and TBS1 and Vd1 bind to talin in a mutually
exclusive manner due to steric conflict (Goult et al., 2013b). A
recent study revealed that a second talin-binding site known
as TBS2 (residues 50–85) in RIAM could also interact with the
R2 and R3 domains of talin (Goult et al., 2013b). However, it isAll rights reserved
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Figure 1. TBS1, Not the TBS2 Region of
RIAM, Interacts with Talin
(A) Schematic diagrams of talin. The head region
possesses four N-terminal FERM domains (ovals),
and the rod region contains 13 helical bundle
domains (R1–R13, each cylinder represents one
helix) and a dimerization helix (DH). Vinculin bind-
ing helices are colored in red.
(B) Schematic diagrams of RIAM. Talin-binding
sites (TBS1 and TBS2) are colored in orange;
coiled-coil (CC) is in red; poly-proline (PP) is in
black; the Ras-association domain (RA) is in yel-
low; and Pleckstrin-homology domain (PH) is in
cyan. Fragments containing residues 1–30 and
27–93 were used in the biochemical characteriza-
tion and functional assays to represent the TBS1
and TBS2 regions, respectively.
(C) GST-tagged TBS1, TBS2, and TBS1-2 (resi-
dues 1–93) were used as bait to pull down GFP-
talin expressed in HEK293 cells. Bound GFP-talin
was analyzed by western blotting. Input GST-tag-
ged RIAM protein levels were shown by Coo-
massie staining.
(D) GST-tagged TBS1, TBS2, and TBS1-2 were
used as a bait to pull down purified recombinant
His6-tagged R2R3 and R7R8 proteins. Bound His-
R2R3 and His-R7R8 proteins were analyzed by
western blotting (upper). Input GST-tagged RIAM
protein levels were shown by Coomassie staining
(lower).
See also Figure S1.
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Crystal Structure of the RIAM-Talin Complexunclear how TBS1 and TBS2 both function in recruiting talin to
the PM. Furthermore, the TBS1 sequence is highly conserved
in lamellipodin (Lpd), a paralogue of RIAM capable of binding
to both talin and Rap1 (Chang et al., 2013; Krause et al., 2004;
Lee et al., 2009). Unlike RIAM, Lpd exhibits little or even
opposing effects on inside-out integrin signaling (Colo´ et al.,
2012; Lafuente et al., 2004; Watanabe et al., 2008). Thus, the
structural and functional characterization of the binding speci-
ficity of the RIAM:talin association is required to elucidate the
molecular mechanisms by which Rap1-induced integrin activa-
tion is regulated by RIAM.
In this study, we investigate RIAM-mediated inside-out integ-
rin signaling using talin1 and a platelet integrin aIIbb3. We
demonstrate that the TBS1 region, but not the TBS2 region, in-
teracts with full-length talin in the cytoplasm and that the R8
domain of talin is the strongest binding site for the TBS1 region.
The TBS2 region only interacts with isolated talin rod domains
weakly and its role in talin recruitment and integrin activation is
insignificant. The crystal structure of a TBS1 peptide in com-
plex with the R7R8 double domains of talin was determined
to 1.5 A˚ resolution. The structure reveals that TBS1 binds to
the R8 domain via both hydrophobic and electrostatic interac-
tions. Unexpectedly, this association also requires a unique,
kinked helical conformation of the bound TBS1 peptide. Muta-
tions of TBS1 that disrupt the kinked conformation or the side-
chain interactions significantly diminished its association with
talin, membrane coclustering of RIAM with talin, and integrin
activation. We also identified a highly conserved TBS1-binding
surface in the talin R3 domain via a structural alignment with
the R8 domain and demonstrated that disrupting binding sitesStructure 22, 1810–18in both the R3 and the R8 domains abolished the RIAM:talin
interaction. Moreover, our analyses suggest that the talin-bind-
ing site in Lpd corresponding to the TBS1 region lacks the he-
lical kink, resulting in a low talin-binding affinity. These results
suggest that only the TBS1 region, but not the TBS2 region,
functions in promoting the talin:integrin interaction and eluci-
date a structural basis for the specific recruitment of talin by
RIAM.
RESULTS
Comparison of RIAM TBS1 and TBS2 Regions in Binding
to Cytoplasmic Talin
The N-terminal flexible region of RIAM preceding the RA domain
(residues 1–178) contains at least three predicted helical se-
quences (Figure 1B: TBS1, TBS2, and CC) (Wynne et al., 2012;
Zhang et al., 2014). Two of these sequences exhibit binding affin-
ities to various talin domains and are named TBS1 and TBS2
(Goult et al., 2013b; Lee et al., 2009). Prior to its translocation
to the PM, the homodimeric talin protein adopts a highly com-
pacted autoinhibitory conformation (Goksoy et al., 2008; Goult
et al., 2013a; Song et al., 2012). This conformation may partially
mask the RIAM-binding domains. To assess the interaction of
TBS1 and TBS2 with full-length cytoplasmic talin, we performed
a pull-down assay using GST-tagged RIAM fragments (TBS1:
residues 1–30; TBS2: residues 27–93; and TBS1-2: residues 1–
93) with full-length talin expressed in mammalian cells. Both
TBS1 and TBS1-2 exhibit a strong association with full-length
talin at similar levels. However, the association of TBS2 with talin
is undetectable in this binding assay (Figure 1C).20, December 2, 2014 ª2014 Elsevier Ltd All rights reserved 1811
Table 1. X-Ray Data Collection and Refinement Statistics
R7R8-TBS1
Data Collection
Space group P21212
Cell dimensions
a, b, c (A˚) 59.7, 105.9, 49.0
a, b, d () 90.0, 90.0, 90.0
Resolution (A˚) 50.0–1.50 (1.53–1.50)
Completeness (%) 98.6 (96.9)
Rsym (%) 5.1 (55.8)
I /s(I) 47.3 (2.9)
Unique reflections 49,933 (2,414)
Redundancy 5.7 (4.5)
Refinement
Resolution (A˚) 50.0–1.50
Rwork (%) 22.3 (28.0)
Rfree (%) 24.2 (30.3)
RMSD bonds (A˚) 0.005
RMSD angle () 0.934
Protein atoms 2,244
Peptide atoms 162
Solvent atoms 305
Total residues 322
Average B-factors (A˚2)
Protein
Main chain atoms 20.6
Side chain atoms 22.9
Peptide
Main chain atoms 18.4
Side chain atoms 19.0
Solvent 36.5
Ramachandran
Favored regions (%) 99.7
Allowed regions (%) 100.0
Rsym = SjIobs – Iavgj/SIavg; Rwork = SjjFobs – Fcalcjj/SFobs; Rfree was calcu-
lated using 5% of the data and the same sums. Values in parentheses are
for highest-resolution shell.
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Crystal Structure of the RIAM-Talin ComplexCharacterization of the Primary RIAM Binding Sites in
Talin
Several talin rod domains including the R3 and R8 domains have
been shown to interact with RIAM TBS1 (Goult et al., 2013b).
Because it is suggested that the four helical-bundle R3 domain
is intrinsically unstable and undergoes unfolding in response to
force exerted on talin (Goult et al., 2013b), we assessed the bind-
ing affinities of RIAM TBS1, TBS2, and TBS1-2 fragments with
talin R2R3 and R7R8 fragments. Recombinant R2R3 and R7R8
proteins were examined by CD spectra to confirm proper folding
(Figure S1A available online). The TBS1 and TBS1-2 fragments
bind to both R2R3 and R7R8 in the in vitro binding assays,
whereas the interactions of the TBS2 fragment with R2R3 and
R7R8 are much weaker (Figure 1D). We then assessed the bind-
ing affinities of TBS1 or TBS1-2 with R2R3 or R7R8 using quan-
titative pull-down assays. While the TBS1-binding affinities of1812 Structure 22, 1810–1820, December 2, 2014 ª2014 Elsevier LtdR2R3 and R7R8 are both in the low micromolar range, TBS1
binds to R7R8 more strongly than R2R3, and the binding affin-
ities of TBS1-2 with R7R8 or with R2R3 are similar to those of
TBS1 (Figures S1B–S1E). These results confirm that both R3
and R8 domains directly bind the TBS1 fragment and suggest
that the R8 domain (in the form of R7R8) is a stronger TBS1-bind-
ing site.
Structure of the RIAM TBS1 in Complex with the
Talin R7R8
To better understand the structural basis for the interaction be-
tween RIAM and talin, we determined the crystal structure of
a RIAM TBS1 peptide (residues 5–25) in complex with the
talin R7R8 domains (residues 1,357–1,657) at 1.5 A˚ resolution
(Table 1). The asymmetric unit possesses one R7R8 molecule
with a well-defined TBS1 fragment (Figure S2A). The TBS1 pep-
tide interacts with the talin R8 domain, but not with the R7
domain (Figure 2A). Although TBS1 also forms hydrogen bonds
with the symmetrically related R7 domain (Figure S2B), removal
of the R7 domain did not affect the association of TBS1 with the
R8 domain, suggesting that these hydrogen bonds are likely
the result of crystal packing. The TBS1 peptide binds to the
R8 domain at the a2 and a3 helices via both hydrophobic
and electrostatic interactions. The association is mediated
primarily through a large hydrophobic contact interface formed
by multiple side chains (Ile8, Met11, Phe12, Leu15, and Leu22
in RIAM TBS1 and Leu1492, Ala1495, Ala1499, Ala1529,
Ala1533, Thr1536, Val1540, Ca of Arg1510, and Lys1544 in
the R8 domain) (Figure 2B) and is further fortified by several
electrostatic interactions (Asp9RIAM-Lys1544talin, Glu18RIAM-
Arg1510talin, and Glu18RIAM-Asn1507talin) (Figure 2C).
Strikingly, in the structure of TBS1:R7R8 complex, the TBS1
peptide adopts an unexpected helical conformation with an
55 kink at the backbone of residue Ser13 (Figure 2D). An
earlier study reported a structure of the RIAM TBS1 in complex
with the vinculin Vd1 domain, in which a conventional a-helical
TBS1 interacted with the a1, a2, and a4 helices of the Vd1
domain (Figure 2D) (Goult et al., 2013b). The side-chain hydrox-
yl group of Ser13 in the R7R8-bound TBS1 forms a hydrogen
bond with the backbone of Gln10 and a water-mediated
hydrogen bond network with the backbones of Met11 and
Thr14 (Figure 2D). These interactions stabilize the helical kink
at Ser13 in the TBS1:R7R8 complex. The kinked TBS1 helix
allows additional hydrophobic side chains proximal to the
N terminus, including Ile8, Met11, and Phe12, to participate in
the hydrophobic interactions with the R8 domain. This confor-
mation also positions the Asp9 residue toward the a3 helix of
the R8 domain to form the Asp9RIAM-Lys1544talin salt bridge.
As a result, the average B-factor for the R7R8-bound TBS1 is
18.4 A˚2 for main chain atoms (18.7 A˚2 for all atoms), represent-
ing a much more stable conformation than that of the Vd1-
bound TBS1 (average B-factor is 56.1 A˚2 for main chain atoms
and 57.1 A˚2 for all atoms) (Figure S2C). The shape complemen-
tary of the TBS1:R7R8 interaction (0.773) is also higher than
that of the TBS1:Vd1 interaction (0.714) (Lawrence and Col-
man, 1993). The refined model was analyzed by MolProbity
(Chen et al., 2010). A total of 99.7% of all residues are in the
favored regions, and 100% of all residues are in the allowed
regions of the Ramachandran plot. The Clashscore is 1.24All rights reserved
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Figure 2. Crystal Structure of the
TBS1:R7R8 Complex
(A) Ribbon diagram representation of the complex
structure of the talin R7R8 domains and the RIAM
TBS1 peptide. R7 domain is colored in cyan; R8
domain is in green; and the TBS1 peptide is in
purple. Left: top view of the R7R8-TBS1 complex.
Right: only the R8 domain and the TBS1 peptide
are shown in the side view. The Ser13 residue
located at the kink is shown as a stick represen-
tation. The two TBS1-interacting helices in R8 are
labeled as a2 and a3.
(B) Hydrophobic interactions are represented by a
light gray surface. Residues of TBS1 are labeled in
black and blue, and residues of the R8 domain are
labeled in black and yellow.
(C) Hydrogen bonds are denoted by a dotted
line.
(D) Superposition of the TBS1 peptide (residues
14–25) from the TBS1:R7R8 structure (purple)
and the structure of TBS1 in complex with the
vinculin Vd1 domain (PDB ID 3ZDL) shows an
55 kink at Ser13. Vd1 helices (ivory) that
interact with TBS1 are labeled (a1, a2, and a4).
The hydrogen bond network mediated by the
side chain of Ser13 is illustrated in the close-in
view.
(E) GST-tagged TBS1 mutations (D9A, S13G,
L15Y, and E18A) were used as bait to pull down
GFP-talin. Bound GFP-talin was analyzed by
western blotting. Input GST-TBS1 (wild-type
and mutants) levels were shown by Coomassie
staining.
(F) Pull-down assay using full-length talin (WT,
T1520Y, and V1540Y) and the RIAM TBS1 frag-
ment. Input GFP-talin (wild-type and mutants)
levels were shown in the lower blot.
(G) Surface representation of the R8 domain and
cartoon diagram of the bound TBS1 peptide.
TBS1 interacting residues that are identical in the
R3 domain are highlighted in yellow, and similar
residues are highlighted in blue. Conserved
residues are highlighted in yellow in the struc-
ture-based sequence alignment of the R8
domain and the R3 domain. V1540 in the R8
domain and V871 in the R3 domain are indicated
by a red dot.
(H) Pull-down of His-tagged talin R2R3 domains
by GST-TBS1 and its mutants (S13G and L15Y).
Input GST-TBS1 (wild-type and mutants) levels
were shown by Coomassie staining.
(I) Pull-down of full-length talin and its mutants
(V871Y, V1540 and V871Y/V1540Y) with GST-
TBS1. Input GFP-talin (wild-type and mutants)
levels were shown by western blotting.
See also Figures S2 and S4.
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Crystal Structure of the RIAM-Talin Complex(99th percentile) and the overall MolProbity score is 0.84 (100th
percentile). Thus, the crystal structure of the R7R8:TBS1 com-
plex suggests that binding to R7R8 induces a more stable
kinked helical conformation of the TBS1 fragment, thus
enhancing the TBS1:talin interaction.Structure 22, 1810–18Identification of the Residues Critical for TBS1:Talin
Binding
To validate the side chain interactions observed in the crystal
structure, we constructed several single point mutations in
the RIAM TBS1 region (D9A, L15Y, and E18A) and a surface20, December 2, 2014 ª2014 Elsevier Ltd All rights reserved 1813
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Crystal Structure of the RIAM-Talin Complexmutation V1540Y in the R8 domain and evaluated their effect on
the association of the RIAM TBS1 region with full-length talin.
Additionally, to assess the contribution of the helical kink to the
interaction, we also mutated Ser13 to a glycine to destabilize
the kink in the RIAM TBS1 region. The D9A mutation in the
RIAM TBS1 fragment and the V1540Ymutation in the R8 domain
diminished the TBS1:talin association, and the other TBS1muta-
tions (L15Y, E18A, and S13G) completely abolished the interac-
tion with full-length talin in the pull-down assays (Figure 2E). In
contrast, another talin surface mutation at a noninteracting res-
idue (T1520Y) in the same helix as V1540Y exhibited no reduc-
tion in RIAM TBS1 binding (Figure 2F). These data demonstrate
that not only the hydrophobic and electrostatic interactions, but
also the helical kink, are required for the high affinity TBS1:talin
association.
The R3 Domain May Bind to RIAM TBS1 via a Highly
Conserved Interface
Although both the talin R3 and R8 domains contain four helical
bundles, their primary sequences are significantly different with
a sequence identity of <20%. Surprisingly, structure-based
sequence alignment of the two domains reveals that the residues
that interact with RIAM TBS1 in the R8 domain are completely
conserved (75% identical and 25% similar) in the R3 domain
(Figure 2G). To examine whether the R3 domain also interacts
with TBS1 via this conserved surface, we assessed the effects
of the corresponding mutations on the association of TBS1
with the R2R3 domains and with full-length talin. Both single mu-
tations, S13G and L15Y of TBS1, significantly diminished the
TBS1:R2R3 interaction (Figure 2H). Furthermore, the V871Y mu-
tation in the R3 domain, equivalent to the V1540Ymutation in the
R8 domain, also diminished the interaction of RIAM TBS1 with
the full-length talin. Strikingly, the V871Y/1540Y mutant abol-
ished the interaction (Figure 2I), suggesting that the interactions
of TBS1 with other talin rod domains are insignificant. These re-
sults suggest that RIAM TBS1 interacts with the talin R3 domain
in a mode highly similar to the TBS1:R8 interaction via a
conserved interface.
Binding Determinants in the TBS1:R7R8 Complex and
the Helical Kink in TBS1 Are Required for RIAM:Talin
Colocalization at the PM and for Integrin Activation
It has been shown that cotransfection of talin and RIAM TBS1,
containing a C-terminal CAAX sequence directing it to the PM,
in stably expressing aIIbb3-integrin A5 cells, bears the capacity
to both activate integrins and facilitate the cell surface cocluster-
ing of these overexpressed proteins (Lee et al., 2009). To assess
the role of TBS1 single mutants in regulating talin recruitment in
integrin signaling, we compared the TBS1 single mutants S13G,
L15Y, and E18A to GFP-RIAM-TBS1-CAAX control for their abil-
ity to cocluster with mCherry-talin. As expected, wild-type TBS1
containing CAAX and talin colocalize and form coclusters at the
lamellae, whereas RIAM TBS1 single mutants S13G, L15Y, and
E18A failed to recruit talin into clusters (Figures 3A and 3B). Gen-
eral Pearson’s correlation coefficient (PCC) showed modest, but
significant higher correlations for wild-type: RIAM-TBS1-CAAX
(0.9434 ± 0.02) compared to S13G (0.9086 ± 0.07), L15Y
(0.8620 ± 0.08), and E18A (0.8726 ± 0.07) (Figure 3C). Nonethe-
less, when calculated solely at the cell’s lamellae (see Experi-1814 Structure 22, 1810–1820, December 2, 2014 ª2014 Elsevier Ltdmental Procedures for details), differences in observed PCC
values were more substantial: RIAM-TBS1-CAAX (0.9539 ±
0.02) compared to S13G (0.8400 ± 0.05), L15Y (0.7076 ± 0.06),
and E18A (0.7785 ± 0.05) (Figure 3D). These results, in full
concordance with our crystal structure and with the in vitro bind-
ing studies, suggest that binding determinants and the helical
kink in TBS1 are required for TBS1:talin coclustering.
We then examined the effect of the TBS1mutations on integrin
activation in a well-accepted fluorescence-activated cell sorting
(FACS) assay. Cotransfection of RIAM TBS1-CAAX and talin
in A5 cells promotes activation of aIIbb3 integrins, and this
effect can be inhibited by EDTA and an aIIbb3 integrin-specific
inhibitor, Eptifibatide (Figure 4A). The TBS1 mutants, including
S13G, L15Y, and E18A, significantly diminish integrin activation
(Figure 4B). Full-length RIAM bearing these mutations also
exhibit impaired function in promoting integrin activation when
coexpressed with talin (Figure 4C). To compare the effect of
TBS1, TBS2, and TBS1-2 on mediating integrin activation, we
deleted TBS1, TBS2, or both (DTBS1, DTBS2, and DTBS1-2)
in RIAM and assessed their effects on integrin activity when
coexpressed with full-length talin. Deletion of TBS1 and TBS1-
2 leads to significant loss of integrin activity, whereas the effect
of DTBS2 is much weaker on altering integrin activity (Fig-
ure 4D). Furthermore, TBS1-CAAX and TBS1-2-CAAX, but not
TBS2-CAAX, are capable of promoting the inside-out integrin
activation (Figure 4E). Together, our results suggest that binding
determinants in the TBS1:R7R8 complex and the helical kink in
the RIAM TBS1 are required for integrin activation and TBS1,
but not TBS2, is essential for talin recruitment in inside-out integ-
rin signaling.
Substitution of RIAM TBS1 with Corresponding
Residues in Lpd Reduces Talin Binding and Impairs
Integrin Activation
RIAMand Lpd affect cell adhesion differently despite their similar
structural architecture with 59% sequence identity in the TBS1-2
and theRA-PH regions (Krause et al., 2004; Lafuente et al., 2004).
Lpd has been identified as anM-Ras effector protein but retains a
moderate Rap1-binding affinity owing to an RA-PH functional
module highly similar to that of RIAM (Lafuente et al., 2004;
Tasaka et al., 2012; Yoshikawa et al., 2007; Zhang et al., 2014).
Lpd also possesses all R8-interacting residues in RIAM TBS1 in
its N-terminal talin-binding site (Lpd-TBS) except a single substi-
tution of Leu15RIAM with Trp31Lpd (Figure 5A). Interestingly, the
Lpd-like L15W mutant retains substantial binding capacity to
talin compared with the L15Y mutant (Figure 5B). However, the
association of RIAM TBS1 with cytoplasmic talin is much stron-
ger than that of Lpd-TBS and talin (Figure 5C). This result is
also confirmed by an in vitro pull-down using a purified talin pro-
tein containing R7, R8, and R9 domains (R7R8R9) (Figure S3A).
Furthermore, the effect of Lpd-TBS-CAAX on promoting integrin
activity is also much weaker than that of RIAM TBS1-CAAX (Fig-
ure 5D). These results suggest that Lpd-TBS lacks other crucial
factors for a tight talin association. We have shown that the
Ser13 residue in RIAM stabilizes the helical kink in the R8-bound
TBS1. This residue is substituted by a glycine residue in Lpd.
The TBS1 fragment (residues 5–25) alone does not possess a
stable secondary structure, and theS13Gmutation does not alter
the conformation of the isolated TBS1 fragment (Figure S3B).All rights reserved
Figure 3. Binding Determinants and the Helical Kink Are Required for the Coclustering of RIAM and Talin at the PM
A5 cells were transiently cotransfected with mCherry-talin and GFP-RIAM-TBS1-CAAX constructs as indicated. 24 hr posttransfection, the cells were plated on
fibrinogen-coated coverslips and allowed to adhere and spread for 1 hr.
(A) Fixed cells were imaged using a spinning-disk confocal microscope and representativemonochromatic and color-merged images are shown. Note that yellow
colors in merged images represent areas of common red and green localizations. Numbers in white correspond to unrefined median PCCs ± SD.
(B) Enlarged lamellae sections correspond to the white rectangles marked in (A). Median PCC values are shown. Note that small histogram graphs in (B) are
representative of intensity levels of the assorted overexpressed proteins. Scale bars in (A) and (B) represent 5 mm.Graphs in (C) and (D) respectively correspond to
(A) and (B) PCC medians (±interquartile range) values.
(C) Data calculated from three experimental repetitions counting with ten images per condition.
(D) Data included nine lamella regions selected from three representative cell bodies per condition. ***p < 0.001.
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Figure 4. Integrin Activity Analyses for TBS1
and TBS2
(A) A5 cells were cotransfected with HA-talin and
GFP-tagged RIAM-TBS1-CAAX. Nonspecific in-
hibitor of integrin (EDTA) and specific inhibitor of
integrin aIIbb3 (Eptifibatide) were added into the
transfected cells before adding PAC-1 antibody.
Integrin activation was detected by PAC-1 binding
using FACS. The MFI of cells cotransfected with
GFP and HA-Talin was defined as 1. *p < 0.001
compared with RIAM-TBS1-CAAX.
(B) A5 cells were cotransfected with HA-talin and
indicated mutants of GFP-tagged RIAM-TBS1-
CAAX. PAC-1 binding was detected as described
in (A). *p < 0.001 compared with wild-type RIAM-
TBS1-CAAX.
(C) A5 cells were cotransfected with HA-talin and
indicated mutants of GFP-tagged RIAM. *p < 0.001
compared with wild-type RIAM.
(D) PAC-1 binding was detected using GFP-RIAM
full length or RIAM with TBS regions deleted con-
structs. *p < 0.001, ** p < 0.01 compared with full
length RIAM.
(E) PAC-1 binding was detected in cells expressing
TBS1, TBS2, and TBS1-2 constructs fused with a
C-terminal CAAX tail. *p < 0.001 compared with
cotransfection of GFP and talin. Data shown in
(A)–(E) are means ± SD, n = 3.
Structure
Crystal Structure of the RIAM-Talin ComplexHowever, the glycine residue is unable to form the hydrogen
bond network that stabilizes the helical kink in the R8-bound
TBS1. To test whether the lack of a stable helical kink leads to
the weak association of talin with Lpd-TBS, we generated a
gain-of-function mutation by mutating the corresponding Gly29
residue to serine in the Lpd-TBS fragment. Indeed, Lpd-TBS-
G29S enhances the interaction of Lpd-TBS and talin (Figure 5C).
This mutation also improves integrin activationmediated by Lpd-
TBS (Figure 5D). Together, these results suggest that talin prefer-
entially binds to RIAM over Lpd via a kinked helical configuration
and favorable side chains of the TBS1 site.
DISCUSSION
Talin recruitment to the PM by RIAM is a key step in inside-out
integrin signaling that promotes the direct interaction between
talin and the C-terminal tail of the integrin b chain (Lee et al.,
2009; Wegener et al., 2007). However, how each of the interact-
ing sites in RIAM and talin function together to recruit and acti-
vate talin still remains unclear. We demonstrate that cytoplasmic
talin only interacts with TBS1, whereas TBS2 does not interacts
with talin nor does it facilitate the TBS1:talin interaction. Although
weak binding was observed between TBS2 with isolated R2R3
or R7R8 domains of talin, our functional studies confirm that
TBS1, but not TBS2, plays an essential role in recruiting talin to
the PM that activates integrins (Goult et al., 2013b). Furthermore,
TBS1 adopts two distinct helical conformations when bound to1816 Structure 22, 1810–1820, December 2, 2014 ª2014 Elsevier Ltd All rights reservedtalin or vinculin. It has been proposed
that the TBS1:vinculin interaction may
play an inhibitory role for integrin activa-
tion (Goult et al., 2013b). Nevertheless,
the B-factors for the R7R8-bound TBS1and Vd1-bound TBS1 are strikingly different, suggesting that
the TBS1 fragment prefers themore stable kinked helical confor-
mation. Talin also possesses 11 vinculin binding sites (VBS) that
bind to the Vd1 domain with much higher affinity than that of the
Vd1 and TBS1 (Gingras et al., 2005; Goult et al., 2013b; Rees
et al., 1990; Yogesha et al., 2011). Thus, it appears that the inter-
action of RIAM and vinculin is rather transient and the main func-
tion of RIAM TBS1 is to recruit cytoplasmic talin to the PM.
The R8 domain that binds to RIAM TBS1 is adjacent to the
autoinhibitory R9 domain. This raises the question of whether
the PM recruitment of talin via RIAM TBS1 may also contribute
to the dissociation of the R9:F3 interdomain complex via steric
conflict. To test this, we generated two talin constructs F0R8
(residues 1–1,653) and F0R9 (residues 1–1,848) that represent
the active form and the auto-inhibited form of talin. No significant
difference is observed between the two forms in binding to TBS1
(Figure S4A). We then titrated purified R7R8 domains or R9
domain of talin into the F0R8 or F0R9-expressing cell lysate (Fig-
ures S4B and S4C). As expected, the R7R8 domains compete
with F0R8 and F0R9 for TBS1 binding. However, the R9 domain
has no effect on the binding of TBS1 with F0R8 or F0R9. Further-
more, although the E1770A mutation in the R9 domain disrupts
the autoinhibitory configuration of talin (Goult et al., 2009; Song
et al., 2012), this mutant retains similar binding capacity to
TBS1 compared to the wild-type talin (Figure S4D). Together,
these data suggest that the autoinhibitory configuration of talin
via the F3:R9 interaction does not conflict with the binding to
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Figure 5. Lamellipodin Lacks the Helical Kink in Its Talin-Binding Region
(A) Schematic representation of Lpd domain organization (Lpd-TBS: talin-binding region, orange; CC: coiled-coil region, red; PP: poly-proline region, black; RA:
Ras-association domain, yellow; and PH: Pleckstrin homology domain, cyan). Lpd-TBS shares conserved talin-binding residues (highlighted in yellow) with RIAM
TBS1. Talin interacting residues are depicted as green dots. A pink cylinder indicates the helical region in TBS1. Blue stars indicate residues that define the
binding specificity in RIAM.
(B) The L15Y mutant that disrupts TBS1-talin binding and the L15Wmutant that mimics Lpd were assessed for talin-binding by pull-down. Bound GFP-talin was
analyzed by western blot. Input GST-TBS1 (wild-type and mutants) levels were shown by Coomassie staining.
(C) TBS1-S13G of RIAM and Lpd-TBS-G29S of Lpd were assessed for talin-binding by pull-down. Bound GFP-talin was analyzed by western blot. Input GST-
tagged protein levels were shown by Coomassie staining.
(D) PAC-1 binding was detected in cells expressing TBS1-CAAX and Lpd-TBS (L60)-CAAX or G29S mutant. Data is shown as means ± SD, n = 3. *p < 0.01
compared with cotransfection of GFP and talin. #p < 0.01 compared with L60-CAAX.
See also Figure S3.
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Crystal Structure of the RIAM-Talin ComplexRIAM TBS1. Nevertheless, a recent study of talin revealed that
the R1-R2-R3 region also interacts with the F2F3 region (Goult
et al., 2013a). Whether this interaction also contributes to talin
autoinhibition and how it may be affected by TBS1 binding re-
quires further investigation.
As the closest paralogue of RIAM, Lpd is unable to promote
integrin-mediated cell adhesion (Lafuente et al., 2004). Our
structural and functional studies of the RIAM:talin association
provided more insight into the unique role of RIAM in mediating
inside-out signaling. We have previously revealed the structural
basis of the specific binding of RIAM and Rap1 and demon-
strated that Lpd also interacts with Rap1 but with a much lower
affinity due to unfavorable side-chain interactions (Zhang et al.,
2014). Here, we showed that talin binds to RIAM much more
strongly than to Lpd. Despite its low affinity to talin, Lpd overex-Structure 22, 1810–18pression may still induce integrin activation in cells over-
whelmed by exogenous talin and integrin, suggesting that the
low affinity of Lpd to its signaling partners may be compensated
by a high concentration of these components (Lee et al., 2009).
Nevertheless, the binding specificity required for the Rap1 asso-
ciation and talin recruitment allows only RIAM, but not Lpd, to
mediate Rap1-induced integrin activation properly under phys-
iological conditions. Furthermore, Lpd has also been shown to
negatively affect inside-out integrin signaling (Lafuente et al.,
2004). What is the possible molecular mechanism for this inhib-
itory effect? We have previously shown that the PM transloca-
tion of RIAM may be autoinhibited by its N-terminal region
that overlaps with the TBS1-2 region (Wynne et al., 2012). Inter-
estingly, in addition to the Lpd-TBS region that corresponds to
the RIAM TBS1, Lpd also possesses another helical region20, December 2, 2014 ª2014 Elsevier Ltd All rights reserved 1817
Structure
Crystal Structure of the RIAM-Talin Complex(residues 72–107) similar to the RIAM TBS2 region (Figure S3C).
It is possible that this TBS2-like region, together with the Lpd-
TBS region, also inhibits PM translocation of RIAM by
mimicking the RIAM TBS1-2 region. Regardless, future efforts
to elucidate the molecular basis of RIAM autoinhibition are
required to assess this mechanism.
EXPERIMENTAL PROCEDURES
Plasmid Construction and Protein Purification
The TALIN rod domains were cloned into themodified pET28a expression vec-
tor with a His6-tag and a TEV protease cleavage site. The RIAM talin-binding
sites were cloned into the pGEX-5X-1 expression vector with a GST-tag.
RIAM talin-binding site 1 (TBS1) consists of residues 1–30 and talin-binding
site 2 (TBS2) consists of residues 27–93. Talin and RIAM point mutations
were constructed using a site-directed mutagenesis method. Plasmids were
transformed into Escherichia coli BL21(DE3) for protein expression. Cells
were grown in LB medium containing kanamycin or ampicillin at 37C until
the A600 reached 0.6–0.7 and induced by adding 0.4 mM IPTG with incubation
continued overnight at 20C for talin and for 3 hr at 37C for RIAM. Protein pu-
rification was carried out at 4C. The cell pellets were resuspended in 20 mM
Tris pH 7.5 with 500 mM NaCl for His-tagged proteins and 50 mM Tris pH 7.5,
150 mM NaCl, and 5 mM DTT for GST-tagged proteins. Cells were then lysed
with an EmulsiFlex-C3 homogenizer (AVESTIN). Protein samples were ex-
tracted from the supernatants using either a HisTrap FF or GSTrap FF column
(GE Healthcare). For crystallization, the His-tag was removed via incubation
with TEV protease and then further purified using a HiTrap Desalting column
and a HisTrap FF column (GE Healthcare).
GST Pull-Down and Western Blotting
For in vitro pull-down assays, purified GST-RIAM proteins were immobilized
on glutathione agarose beads and then incubated with purified His-tagged ta-
lin proteins in reaction buffer (20 mM Tris-HCl pH 7.5, 100 mM NaCl, and
2 mM DTT) to a total volume of 250 ml on a rotator for 1 hr at 4C. Binding
curves were fit to a single-site (saturating) binding model using SigmaPlot (Sy-
stat Software). For cell lysate pull-down assays, HEK293T cells were trans-
fected with various GFP-talin constructs using Lipofectamine 2000 reagent
(Invitrogen) and lysed 48 hr posttransfection with lysis buffer (20 mM Tris-
HCl pH 7.5, 150 mM NaCl, 5 mM MgCl2, 1% (v/v) Triton X-100, 1 mM DTT,
and complete protease inhibitor cocktail [Roche]). The cell lysates (400 mg
per reaction) were clarified by centrifugation, and supernatants were mixed
with the purified GST-RIAM proteins immobilized on 50 ml of 50% slurry of
glutathione agarose beads and incubated on a rotator for 1 hr at 4C. The
bound proteins were washed three times in 500 ml of the lysis buffer and
were eluted using an elution buffer (20 mM Tris-HCl pH 7.5, 100 mM NaCl,
2 mM DTT, and 10 mM reduced glutathione) at 4C. The proteins were
resolved by SDS-PAGE and detected by Coomassie staining or western blot-
ting. The Immobilon-P transfer membranes (EMDMillipore) were blocked with
TBST buffer (20 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.1% (v/v) Tween 20)
containing 5% (w/v) BSA for 1 hr and then incubated with anti-His (Sigma)
or anti-GFP antibody (Clontech) for 1 hr at room temperature followed by a
second incubation with HRP-conjugated secondary antibody (Santa Cruz
Biotechnology). The blots were visualized with the SuperSignal West Pico
Chemiluminescent Substrate (Thermo Scientific) and detected using the Flu-
orChem E imager (ProteinSimple).
X-Ray Crystallography
The RIAM peptide consisting of residues 5–25 (Genemed Synthesis) was dis-
solved in 100 mM Tris pH 8.0 with 100 mMNaCl and the final pH was adjusted
to pH 7-8. Talin R7R8 (11 mg/ml) was incubated with the RIAM peptide on ice
at a 1:3 molar ratio prior to the crystallization setup. The talin R7R8 domains-
RIAM peptide complex was crystallized using the hanging-drop vapor diffu-
sion method at room temperature, with the droplets containing equal volumes
of protein and reservoir solution. The crystals were grown in 100 mM NaCl,
20% (w/v) polyethylene glycol 3350 and 20% (v/v) ethylene glycol from micro-
seeding. The crystals were grown for 2–3 days and then flash-frozen in liquid
nitrogen prior to the diffraction experiments.1818 Structure 22, 1810–1820, December 2, 2014 ª2014 Elsevier LtdFinal X-ray diffraction data were collected using beamline X29 of the Na-
tional Synchrotron Light Source at the Brookhaven National Laboratory (Up-
ton, NY). Data were processed using the HKL-2000 package (Otwinowski
and Minor, 1997). The complex structure of the talin R7R8 domains and the
RIAMTBS1was determined bymolecular replacement using talin rod residues
1,359–1,659 (Protein Data Bank [PDB] ID 2X0C) as the initial search model
(Gingras et al., 2010). Structural refinement was performed using REFMAC
(Murshudov et al., 1997) and Coot (Emsley and Cowtan, 2004). The models
were validated with SFCHECK (Vaguine et al., 1999) and MolProbity (http://
molprobity.biochem.duke.edu/). Data collection and refinement statistics are
listed in Table 1. Structural figures were generated using the PyMOL program
suite (http://pymol.sourceforge.net). The final atomic model contains residues
1,357–1,651 of chain A (talin) and residues 5–25 of chain B (RIAM). The atomic
coordinates and structure factor have been deposited in the Protein Data Bank
under the accession number 4W8P.
Confocal Imaging and Pearson’s Correlation Coefficient Analyses
Coclustering of RIAM and talin was performed as previously described
(Zhang et al., 2014). Briefly, CHO cells stably expressing aIIb3 integrins (A5
cells) were cotransfected with mCherry-talin and either GFP-RIAM-TBS1-
CAAX or the assorted mutants. Twenty-four hours postcotransfection, the
cells were allowed to adhere and spread on glass coverslips coated with
10 mg/ml fibrinogen for 1 hr at 37C and then fixed with 4% (w/v) paraformal-
dehyde for 30 min at room temperature. The fixed cells were washed with
PBS buffer and mounted with ProLong Gold antifade reagent (Molecular
Probes). Images were acquired using a 603 1.45 Pan APO TIRF oil immersion
objective using a Nikon TE-2000U microscope (Optical Apparatus) equipped
with the Ultraview spinning-disc confocal (Perkin-Elmer Life Sciences). Using
Velocity 6.3, the software was instructed to acquire double channel simulta-
neous sequential images at 488 nm (GFP) and 568 nm (mCherry) wave-
lengths. Image files were captured as 0.1 mm-thick z slices and processed
to obtain maximum projections. Ten cells per condition were analyzed corre-
sponding to three independent experimental repetitions. Pearson’s correla-
tion coefficients (PCCs) were obtained from whole cells as well as lamellar
locations using MetaMorph offline 7.8 software (Molecular Devices). Cellular
lamellae areas were selected using RIAM’s GFP intensities to detect the
cell edge, while cellular centroids were identified using the same MetaMorph
software. The outermost 5 mm measured from the cell’s centroid constituted
lamella positive areas.
Integrin Activation Assay
A5 cells were cotransfected with HA-talin and GFP-tagged RIAM or Lpd vec-
tors. Twenty-four hours after transfection, the cells were resuspended by tryp-
sinization and washed with Tyrode’s buffer (136.9 mM NaCl, 10 mM HEPES,
5.5 mM glucose, 11.9 nM NaHCO3, 2.7 mM KCl, 0.5 mM CaCl2, 1.5 mM
MgCl2, and 0.4 mM NaH2PO4, pH 7.4). PAC-1 mAb (Becton Dickinson Immu-
nocytometry System), which specifically recognizes activated integrin, was
then added to the cell suspension and incubated for 1 hr at 4C. The cells
were washed by Tyrode’s buffer and incubated with Alexa Fluor 647 conju-
gated goat anti-mouse IgM antibody for 1 hr on ice and resuspended in cold
PBS. To specifically inhibit integrin activation, 10 mM EDTA or 10 mMEptifiba-
tide was incubated with cell suspension for 20 min before adding PAC1 anti-
body. Stained cells were analyzed using the LSRII FACS instrument (BD
Scientific). The collected data were processed using the FlowJo software
package and expression levels of talin were examined by western blot (Fig-
ure S5). Only GFP-positive cells were gated on to analyze PAC-1 binding.
The mean fluorescence intensity (MFI) of PAC-1 channel of each transfectant
was normalized to that of the GFP empty vector and HA-talin cotransfection to
obtain the relative MFI. The data were represented by the means ± SD from at
least three experiments. The equal expression of talin under each condition
was verified by western blot using anti-HA antibody (Figure S5). The unpaired
t test was performed to calculate the p value using GraphPad software.
CD Spectroscopy
CD spectra were recorded in a 0.1 cm pathlength quartz cell on a CD spec-
trometer (model 62A DS; Aviv Associates). Proteins (R2R3 and R7R8) or pep-
tides (TBS1 and TBS1-S13G) were measured at 0.5 mg/ml concentration.
Spectra were recorded at 25C over a wavelength of 200–300 nm.All rights reserved
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